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Abstract: Introduction: A synthetic polymer polyethylene glycol (PEG), was conjugated to fibrinogen
as a threedimensional and biodegradable skin wound dressing matrix. This PEG-fibrinogen (PEG-fib)
was tested in vivo in a skin wound time course study for its biocompatibility and biodegradation, after
being delivered into the wound by injection and polymerized in situ by photo-activation. Materials and
methods: The nature of the inflammatory response to the implanted material in acute, 8 mm diameter,
full-thickness skin lesions in rats was histologically evaluated at 7 days (n=6) and 14 days (n=6). Six
wounds per time point were left untreated as controls. Results: After 14 days, wounds of both groups were
healed by up to 78% contraction and 22% epithelialization. Immune cells such as foreign body giant cells,
macrophages, plasma cells and lymphocytes were seen in the PEGfib treated wounds at both time points,
however in low numbers and similar to controls. The amount of immune cells dropped between day 7
and 14. Remnants of the gel were found at day 7 in two of the PEG-fib treated wounds, no PEG-fib were
found after 14 days in any of the wounds. There was no difference in epithelialization between the two
treatments at both time points. Discussion: The histological evaluation showed good biocompatibility
of the PEG-fib, such that a foreign body reaction to the implant could be ruled out. The amount of
immune cells was in accordance to a normal reaction to an implanted resorbable biomaterial. Conclusion:
The PEG-fib hydrogel is fully biocompatible as a skin wound dressing. It provides initial moisture to
the wound bed and is gradually resorbed and replaced by structured skin tissue. An attractive future
perspective would be to prepopulate the PEG-fib hydrogel with cells (e.g. fibroblasts), or load it with
growth factors or other soluble mediators to further promote healing of complicated skin wounds.
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Abstract
Introduction: A synthetic polymer polyethylene glycol (PEG), was conjugated to fibrinogen as a three-
dimensional and biodegradable skin wound dressing matrix. This PEG-fibrinogen (PEG-fib) was tested in vivo in 
a skin wound time course study for its biocompatibility and biodegradation, after being delivered into the wound by 
injection and polymerized in situ by photo-activation.
Materials and methods: The nature of the inflammatory response to the implanted material in acute, 8 mm 
diameter, full-thickness skin lesions in rats was histologically evaluated at 7 days (n=6) and 14 days (n=6). Six 
wounds per time point were left untreated as controls.
Results: After 14 days, wounds of both groups were healed by up to 78% contraction and 22% epithelialization. 
Immune cells such as foreign body giant cells, macrophages, plasma cells and lymphocytes were seen in the PEG-
fib treated wounds at both time points, however in low numbers and similar to controls. The amount of immune cells 
dropped between day 7 and 14. Remnants of the gel were found at day 7 in two of the PEG-fib treated wounds, no 
PEG-fib were found after 14 days in any of the wounds. There was no difference in epithelialization between the two 
treatments at both time points.
Discussion: The histological evaluation showed good biocompatibility of the PEG-fib, such that a foreign body 
reaction to the implant could be ruled out. The amount of immune cells was in accordance to a normal reaction to an 
implanted resorbable biomaterial.
Conclusion: The PEG-fib hydrogel is fully biocompatible as a skin wound dressing. It provides initial moisture 
to the wound bed and is gradually resorbed and replaced by structured skin tissue. An attractive future perspective 
would be to prepopulate the PEG-fib hydrogel with cells (e.g. fibroblasts), or load it with growth factors or other 
soluble mediators to further promote healing of complicated skin wounds.
Keywords: Biocompatibility; Wound healing; PEG-fibrinogen 
hydrogel; In vivo; Rat
Introduction
Acute or chronic skin defects with tissue loss are very common. The 
challenges in dealing with these are the long healing times, excessive 
scar tissue formation and impaired skin function. The duration of open 
wound management can significantly contribute to patient morbidity 
and increased cost of treatment [1,2].
Adult skin wound healing takes place largely by repair rather than 
by regeneration [3]. There is evidence that the inflammation during 
wound healing is directly responsible for fibrosis and the extent of scar 
formation [4]. In contrast regenerative healing has a notable reduction 
of inflammatory cell activity compared to repair tissue [5]. During the 
wound healing process, dressings should maintain suitable wound 
moisture, prevent microbial microfilms, remove dead spaces and be 
permeable for moisture and oxygen [6]. Conventional passive and 
non-resorbable wound dressings may adhere to the wound surface 
and the need for their frequent changes traumatizes newly built tissue 
[7]. Different types of newly developed resorbable wound dressings 
have - to some extent - overcome these disadvantages. Ideally they give 
structural support for cell ingrowth, are fully biocompatible (non-toxic 
and non-immunogenic), resorbable and undergo biodegradation at the 
rate of new tissue formation [6-10]. 
Biocompatibility is defined as “the ability of a material to perform 
with an appropriate host response in a specific situation” [11]. 
Biocompatible implants do not form a fibrous layer or capsule around 
the implant after the early inflammatory response has subsided [12] 
and show low counts of specific immune cells like lymphocytes, plasma 
cells and foreign-body giant cells (FBGCs). However, certain numbers 
of macrophages and FBGCs are needed for material degradation [13].
Scaffolds for skin regeneration or repair can consist of biological 
or synthetic materials. Although they play mainly a structural role in 
the wound site, some scaffolds may also provide signal transduction 
for wound healing. Biological materials such as collagen or fibrin may 
provide bio-functional signals that can promote tissue regeneration 
[14], but are not stable enough to remain in the wound for the entire 
healing process. Furthermore, these materials are often hampered by 
large batch-to-batch variability and non-uniform in situ degradation 
[10,15]. In contrast synthetic polymers such as polyethylene glycol 
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(PEG) are easily controlled in terms of their physical and degradation 
characteristics, but are completely lacking bioactivity and cell signaling 
domains [16]. These materials also resist cell adhesion [17]. 
As a skin wound dressing, the combination of the synthetic 
polymer PEG with fibrinogen [18,19] addresses drawbacks of biological 
materials that outweigh the effects on the benefits of synthetics. 
Fibrinogen can be conjugated with linear polyethylene glycol diacrylate 
(PEG-DA) to create a PEGylated fibrinogen hydrogel scaffold [20]; the 
process is called PEGylation.
The main advantage of PEGylated natural protein biomaterials [21-
28] is their unique features. The synthetic PEG provides the biophysical 
and structural properties of the hydrogel. The fibrinogen directs the 
biological response based on biological cell signaling domains on the 
protein that are tissue repair specific [29]. These signals encourage 
migration, attachment and differentiation of endothelial cells and 
smooth muscle cells [21,30]. Additionally, the fibrinogen affords 
the scaffold proteolytic sensitivity for in situ biodegradation by cell 
activated protease activity [31]. It has been shown, that PEG-fibrinogen 
is degraded in vivo by surface erosion, with a remarkably low foreign 
body response [32,33].
Moreover, the high water content of the PEG-fibrinogen helps 
to establish a physiological extracellular environment that stimulates 
dermal tissue healing [8]. The material is non-toxic [22,29] and 
compatible with a number of different cell types [29]. The in situ 
hydrogel gelation allows a homogeneous integration with the wound 
and the gelation reaction can be carried out in the presence of a mild 
photoinitiator and long-wave ultraviolet light [21,34,35]. 
The physical characteristics and the degradation kinetics of the 
material, such as porosity, swelling, compliance, bulk density, and 
degradability can be adjusted to the individual needs of the application 
by altering the composition of the constituents [21]. Most of the 
structural properties of the PEG-fibrinogen hydrogel are defined by the 
synthetic PEG component [21]. Modifications to the hydrogel network 
structure are possible by changing the combination of the synthetic 
PEG and endogenous fibrinogen. 
To date, PEG-fib has been successfully tested in vitro as a three-
dimensional cell culture scaffold [21,25,27,31,36-39]. In vivo, PEG-fib 
has been applied in wounded bone [24], heart [40,41] and skeletal 
muscle [42] but has yet to be tested in a skin wound healing application. 
Using the PEG-fib as a primary resorbable wound dressing that 
mimics the provisional fibrin ECM and enables cell ingrowth may be 
a promising approach.
This preliminary comparative study aims to assess the suitability 
of PEG-fib as a three-dimensional skin repair matrix. Secondarily, we 
aim to assess the nature of the inflammatory response on the implanted 
material. 
The hypotheses of this preliminary study were that i) the material 
accelerates wound closure compared to untreated control wounds and 
ii) the PEG-fib hydrogel is biocompatible and resorbable within the test 
period of 14 days.
Materials and Methods
Study design
A case control study in experimental animals was performed. 
Wounds of 8 mm diameter were created in the back of six rats. The 
rats were randomly assigned to the 7 or 14 days group. In every rat, 
two wounds were treated with the hydrogel and two left untreated. The 
allocation of the 24 wounds to the PEG-fib “hydrogel treatment” or “no 
treatment” resulted in 3 cranial and 3 caudal wounds for each treatment 
group and time point. After sacrifice the wounds were evaluated 
macroscopically and histologically.
Experimental animals
Six Sprague Dawley rats with a body weight of 168–180 g (mean 
173.5 ± 5.28 g) and an age of 6 weeks were used. The survival times 
were 7 days (group 1, n=3) and 14 days (group 2, n=3) after surgery. The 
animals were held in groups of three in standard individually ventilated 
cages with access to standard rat food (M/R Haltung Extrudat, Provimi 
Kliba) and conditioned water (ProMinent) ad libitum. The animal 
study was conducted according to the Swiss law of animal protection 
and welfare and was permitted through the official Swiss authorities 
(permission # 150/2013).
PEG-DA synthesis and protein PEGylation
PEG-DA was prepared from linear PEG-OH (MW 10 kDa; 
Fluka, Buchs, Switzerland) and characterized according to protocols 
described elsewhere [21]. Briefly, acrylation of PEG-OH was carried 
out by reacting a dichloromethane (Aldrich, Sleeze, Germany) solution 
of PEGOH with acryloyl chloride (Merck, Darmstadt, Germany) and 
triethylamine (Fluka) at a molar ratio of 150% relative to the –OH 
groups. The final product was precipitated in diethyl ether and dried 
under vacuum for 48 h. The PEGylation of human fibrinogen (Tisseel, 
Baxter AG, Vienna, Austria,) was performed according to protocols 
described by Dikovsky et al. [22]. Briefly, tris (2-carboxyethyl) 
phosphine hydrochloride (TCEP HCl) (Sigma) was added to a 3.5 mg/
ml solution of fibrinogen in 50 mM PBS with 8M urea (molar ratio 1.5:1 
TCEP to fibrinogen cysteine). After dissolution, a solution of PEG-
DA (280 mg/ml) in 50mM PBS and 8M urea was added and reacted 
overnight. The molar ratio of PEG to fibrinogen cysteins was 5:1 (linear 
PEG-DA, 6 and 10 kDa). The PEGylated protein was precipitated by 
adding 4 volumes of acetone (Frutarom, Haifa, Israel). The precipitate 
was re-dissolved at 10 mg/ml protein concentration in PBS containing 
8M urea and dialyzed against 50 mM PBS. 
The sterile PEG-fib products were characterized for total protein 
concentration using a Nanodrop2000 (Thermo Scientific, Waltham, 
Massachusetts, USA). The rheological properties and the degree of PEG 
substitution were evaluated based on previous studies [22,43].
Surgery and in-life phase
The animals were positioned in ventral recumbency in general 
anesthesia (Induction 20 mg/kg BW Ketamine hydrochloride 
subcutaneously (s.c.), maintenance Isofluran (Attane TM Isofluran, 
Provet Ag, Lyssach, Switzerland) 2.5 Vol%/0.7 l/min O2 via facemask). 
A template was used to standardize the location and distance of the 
wounds. Four full-thickness excisional wounds (8 mm diameter, Figure 
1) were created under aseptic conditions in the back of the rats using a 
biopsy punch (Biopsy Punch, Ø 8 mm, Stiefel Laboratories SRL, Milano, 
Italy). The hydrogel precursor solution, containing 4.7% (w/v) PEG-
DA, 0.7% (w/v) PEG-fib and 0.1% (w/v) Irgacure®2959 photo-initiator 
(Ciba Specialty Chemicals, Basel, Switzerland) was applied to two 
randomly selected wounds of the four. The PEG-fib was cross-linked by 
5 min exposure to long-wave UV light (λ=365 nm, I=5 mW/cm2). The 
two untreated wounds served as control. A bandage (Urgocell lite (Urgo 
GmbH, Sulzbach, Germany) was applied covering all four wounds and 
fixed with Leukoplast (BSN Medical GmbH, Hamburg, Germany). In 
the 14-days survival group the bandage was changed after 7 days.
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Buprenorphine (Temgesic®, Essex Chemie AG, Luzern, Switzerland) 
0.075 mg/kg BW was applied s.c. immediately after surgery. This was 
repeated 3 times every 8 h and thereafter an oral dose of 0.6 mg/250 ml 
in drinking water was given for two days. The animals were monitored 
twice a day for clinical signs of pain or discomfort and the bandage was 
checked for functionality.
Tissue harvest and histology technique
After 7 or 14 days, respectively, the animals were euthanized by 
intracardial injection of 2 mL Pentobarbital (Esconarkon, Streuli Pharma 
Ag, Uznach, Switzerland) with the animals being unconscious in CO2 
anesthesia. The bandages were removed and pictures of the wounds 
were taken (Figures 2a and 2b). The skin squares, each containing one 
wound were excised and pin-fixed on a Styrofoam block (Figure 3). 
After fixation with 4% formaldehyde for 1 day, the samples were paraffin 
embedded and 3 µm cross-sections were obtained perpendicular to the 
skin surface in the center of each circular wound. The sections were 
stained with Haematoxilin-Eosin (H&E) for microscopic examination 
and wound area measurements. Immuno-histochemically the sections 
were prepared for assessment of the presence of myofibroblasts by the 
analysis of alpha-smooth muscle actin expression.
Evaluation
PEG-fib hydrogel-treated and untreated wounds were compared 
for macroscopic appearance of wounds including discharge, swelling, 
reddening using a customized score (0: none, 1: mild, 2: moderate, 3: 
severe discharge/swelling/reddening). This was evaluated by one of the 
authors (KN) in a blinded fashion. For histological assessments, the 
following aspects were compared: presence of a basal membrane, amount 
of immune cells, number of transected blood vessels, granulation 
tissue maturity, wound size, length of new epithelium formation, scar 
thickness, horizontal wound contraction, scar depression and alpha-
SMA expression.
Three observers with experience in wound healing histology (KN, 
VJ, AK) examined sections from each wound in a blinded fashion. 
The scores given by the three observers were averaged for each 
section. Qualitative wound healing parameters were obtained, such 
as the presence of a basal membrane as a sign for the restoration of 
an intact basement membrane zone connecting the epidermis and the 
underlying dermis. 
The H&E stained sections were semi-quantitatively evaluated with 
a microscope (Leica MDL 505097, Leica Instruments GmbH, Nussloch, 
Germany) using a modified score [44,45] given in Table 1. The presence 
of immune cells (granulocytes, macrophages, lymphocytes, FBGCs) and 
material remnants was recorded as the mean of two non-overlapping 
high power optical fields (HPF) per section (20x magnification). One 
HPF was located at the periphery of the lesion, the other one in the 
middle (Figure 4). As a sign for the proliferative phase, the genesis of 
new capillaries was evaluated by the presence of preexisting vessels 
adjacent to the wound. Transected vessels were counted in one HPF 
within the granulation tissue at the center of the defect. Additionally, 
granulation tissue maturity was evaluated in terms of its principal 
cellular composition and the extent and regular arrangement of newly 
formed extracellular matrix.
The quantitative evaluation included several measurements 
(H&E stained histological sections) using the measurement tool of a 
specialized software program (Image access Standard 12, Glattbrugg, 
Switzerland). The evaluation was modified according to previously 
published methods [46,47] (see Figure 5).
The total wound area (TWA) was taken as the linear distance (µm) 
between wound and marginal tissue according to [47]. The open wound 
(OW) was taken as the length of the non-epithelized defect. The scar 
thickness at the defect center (STC) and at both wound margins (STM) 
Figure 1: Surgery: Situation after punch biopsy of four full-thicknesses 8 mm diameter skin defects in a rat. 
PEG-fibrinogen hydrogel is already applied to wound A and C. Note the elliptical deformation of wound D according 
to skin tension (arrow).
Figure 1: Surgery: Situation after punch biopsy of four full-thicknesses 8 mm 
diameter skin defects in a rat. PEG-fibrinogen hydrogel is already applied to 
wound A and C. Note the elliptical deformation of wound D according to skin 
tension (arrow).
Figure 2a: Skin wounds 7 days post-surgery. A, D: Hydrogel-treated; B, C: Untreated 
controls.
Figure 2a: Skin wounds 7 days post-surgery. A, D: Hydrogel-treated; B, C: 
Untreated controls.
Citation: Venzin CM, Jacot V, Berdichevsky A, Karol AA, Seliktar D, et al. (2016) Biocompatibility of Pegylated Fibrinogen and Its Effect on Healing of 
Full-Thickness Skin Defects: A Preliminary Study in Rats. J Biotechnol Biomater 6: 233. doi:10.4172/2155-952X.1000233
Page 4 of 10
Volume 6 • Issue 2 • 1000233
J Biotechnol Biomater
ISSN: 2155-952X JBTBM, an open access journal 
Figure 2b: Healed skin wounds 14 days post-surgery, A, D: Untreated; B, C: Hydrogel 
treated.
Figure 2b: Healed skin wounds 14 days post-surgery, A, D: Untreated; B, C: 
Hydrogel treated.
Figure 3: Pin-fixed skin sample before fixation (survival time 14 days, 
treatment: PEG-fibrinogen hydrogel).
i re : i -fix  ski  sa l  b f r  fix ti  (surviv l ti  14 days, 
t ent: PEG-fibrinogen hydrogel).
Figure 4: Histological section (14 days after surgery, staining: H&E) showing areas for 
evaluation of cell population, maturity of granulation tissue (periphery und center), and 
blood vessel cuts (center). 
Figure 4: Histological section (14 days after surgery, staining: H&E) showing 
areas for evaluation of cell population, maturity of granulation tissue (periphery 
und center), and blood vessel cuts (center). 
Figure 5: Histological section (7 days after surgery, staining: H&E) of wound 
area, illustrating measurements for: 
TWA: Total Wound Area: Linear distance (µm) between wound and marginal 
tissue, open wound; 
OW: Open Wound: Length of the non-epithelized defect;
STC: Scar Thickness at the defect center and at both wound margins (scar 
thickness margin: STM), measured from the top surface of the wound down to 
the panniculus carnosus. 
was measured from the top surface of the wound down to the panniculus 
carnosus and taken as an indicator of the quantity of granulation tissue 
formed within the differently treated wounds [48]. 
Variables calculated
Horizontal contraction rate (HCR) was the defect size at surgery (8 
mm) minus size of histological visible total wound area (TWA) in % 
taken as a measure of wound contraction. If no contraction had occurred, 
the wound width would be expected to remain at 8 mm, any reduction 
was considered to be wound contraction. Newly built epithelium (NBE) 
as a sign for the creation of a permeability barrier (re-epithelialization) 
was the TWA at sacrifice minus OW. The scar depression (VCR, vertical 
contraction rate) was the difference between scar thickness on wound 
margins (mean value of left and right margin) and center in %. The 
immunohistological stained sections were semi-quantitatively scored 
for the amount of alpha-SMA expression (Score see Table 1).
Statistics 
Results were statistically evaluated using ANOVA, for the evaluation 
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of statistical significances the Bonferroni post-hoc test was performed. 
The level of significance was set as p<0.05.
Results
Surgery and in-life phase
Surgery and recovery from anesthesia were uneventful for 
all animals. The liquid hydrogel precursor solution was easily 
administered into the wound and polymerized within 5 min of UV 
light exposure. Upon cross-linking, the PEG-fib hydrogel precursor 
solution transitioned into a solid, elastic gel material that was not 
absorbed by the bandage. The bandages were well tolerated by the 
animals.
Macroscopical evaluation of wound healing
Macroscopically all wounds healed without complications and 
signs of unusual inflammation like reddening, swelling and severe 
discharge. After 7 days, most of the wounds showed a mild to 
moderate serous or sero-sanguinous discharge with no differences 
between treatments. After 14 days, a total of 6/12 wounds were 
completely healed, of which 5 were PEG-fib hydrogel treated and 
1 was an untreated wound. The other wounds were evaluated as 
“in epithelialization”, “almost closed” or with “very small defect”. 
Otherwise no obvious differences between groups in wound or peri-
wound appearance were detected.
Histological evaluation
Qualitative evaluation: A basal membrane was formed in most of 
the controls (controls: 5/6, PEG-fib 2/6) after 7 days and in all samples 
after 14 days (see Table 2). No fibrous layer was detected in any of the 
sections.
Semi-quantitative evaluation: The cell counts at the margin 
and in the center of the wounds, respectively, showed no significant 
differences between controls and treated wounds at both time points; 
an evaluation score of 2 was never exceeded. (Table 2). Significantly 
fewer granulocytes (p=0.004) and macrophages (p=0.008) were found 
in the middle of the wound after 14 days when comparing the 7 and 14 
day results in the control group. This difference was smaller and not 
significant for the hydrogel group (Table 2).
No material remnants could be seen in all evaluated sections (both 
groups and time points) at the edge of the wound while in the middle 
of the wound up to 25% material remnants (Score 1) were found in 2 
sections of the 7-days-group (Table 2) as an eosinophilic layer. This was 
not seen in the 14 days group. However, differences were not statistically 
significant (p=0.221).
After 7 days blood vessels were seen in treated and control wounds. 
The mean score for both the control and the hydrogel group was 3; after 
14 days the score was reduced to 1 for both groups, with no significant 
Score 0 Score 1 Score 2 Score 3 Score 4
Cell counts 0 cells 1-10 cells 11-30 cells 31-60 cells >60 cells
Blood vessels 0 1-5 vessel cuts 6-10 vessel cuts >10 vessel cuts -
Material remnants 0 <25% 25-50% 51-100% -
Maturity of granulation tissue Immature Partially mature Mostly mature Completely mature -
Basal membrane Not present Present - - -
α-SMA expression 0 Low Moderate High Very high
Table 1: Scores for evaluation of histological sections. The scores are based on the counts for immune cells (granulocytes, lymphocytes, macrophages, and foreign 
body giant cells), blood vessels, material remnants (percentage from original amount), maturity of granulation tissue, the presence of a basal membrane and alpha-SMA 
expression per optical high power field, 20x magnification.
Survival time: 7 days Survival time: 14 days Comparison 7 and 14 days: p-value
PEG-fib Control PEG-fib Control
Granulocytes edge 1.0 ± 0.63 1.33 ± 0.52 1.0 ± 0.63 0.5 ± 0.55 -
Granulocytes center 1.17 ± 0.41 1.5 ± 0.55* 0.67 ± 0.52 0.33 ± 0.52* *0.004
Lymphocytes edge 1.67 ± 0.82 1.67 ± 0.82 1.0 ± 0.63 1.0 ± 0 -
Lymphocytes center 1.5 ± 0.55 2.0 ± 0.89 1.0 ± 0.63 1.0 ± 0.63 -
Macrophages edge 2.0 ± 1.27 1.83 ± 1.17 0.83 ± 0.98 0.5 ± 0.55 -
Macrophages center 1.5 ± 0.55 2.0 ± 0.63* 0.83 ± 0.75 0.67 ± 0.52* *0.008
FBGC edge 0.17 ± 0.41 0.17 ± 0.41 0 ± 0 0 ± 0 -
FBGC center 0.17 ± 0.41 0.17 ± 0.41 0 ± 0 0 ± 0 -
Material remnants edge 0 ± 0 0 ± 0 0 ± 0 0 ± 0 -
Material remnants center 0.33 ± 0.52 0 ± 0 0 ± 0 0 ± 0 -
Blood vessels center 2.67 ± 0.52*1 2.67 ± 0.52*2 1.17 ± 0.41*1 1.17 ± 0.41*2
*10.01
*20.01
α-SMA expression 0.67 ± 0.82 1.0 ± 1.10 0.33 ± 0.82 0 ± 0 -
Maturity edge 1.67 ± 1.03 1.67 ± 0.82 2.33 ± 0.52 2.67 ± 0.52 -
Maturity center 1.33 ± 0.82*1 1.33 ± 0.52*2 2.67 ± 0.82*1 2.5 ± 0.55*2
*10.019
*20.049
Basal membrane 0.67 ± 0.52 0.83 ± 0.41 1 ± 0 1 ± 0 -
Table 2: Semi-quantitative and qualitative evaluation of histological sections, showing mean scores in the center or at the edge of the skin defect of: cell counts (Granulocytes, 
lymphocytes, macrophages, Foreign body Giant Cells (FBGC), material remnants, vessel counts, alpha-SMA expression, granulation tissue maturity and the presence 
of a basal membrane (n=12 wounds/time point). For the scores see Table 1. Differences between treated/untreated wounds were not significant; * indicates a significant 
difference between 7 day value and 14 days value, -: difference not significant.
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differences comparing the treated and untreated wounds at both time 
points (Table 2). The reduction of vessel counts between day 7 and 14, 
however, was significant for both groups (p=0.001, see Table 2).
Comparison of granulation tissue maturity showed no significant 
differences between treated and untreated wounds at both time points. 
Comparison of maturation over time showed that the tissue matured 
significantly between day 7 and day 14 for the treated (p=0.019) and 
untreated (p=0.049, see Table 2) wounds.
Quantitative and calculated values: The mean diameter of the 
total wound area (TWA) was larger for the PEG-fib hydrogel treated 
wounds after 7 days (PEG-fib: 4085 µm, control: 3470 µm). This was 
reversed after 14 days (PEG-fib: 1792 µm, control: 2778 µm). Therefore, 
the reduction of total wound area over time was only significant for 
the PEG-fib hydrogel group (p=0.014), but not for the control group 
(Table 3).
A similar pattern was found for the diameter of the open wound 
(OW). After 7 days it was smaller in the untreated controls (1212 µm), 
as compared to the PEG-fib hydrogel treated wounds (2074 µm), but 
after 14 days this reversed to larger open wounds in untreated (404 µm) 
than in PEG-fib hydrogel treated wounds (no defect visible). The open 
wound diameter reduction over time was only significant for the PEG-
fib hydrogel group (p=0.024) (Table 3).
The scar at the two histologically visible wound edges after 7 days 
was thicker for the hydrogel treated wounds (mean 1017 µm ± 126) 
than that of the untreated controls (808 µm ± 227). The reverse pattern 
was seen after 14 days (PEG-fib hydrogel: 592 µm ± 111, control: 608 
µm ± 48). However, these differences between the treatments were not 
statistically significant at both time points (Table 3). 
The measurement of the scar thickness in the middle of the 
wounds showed a similar pattern. After 7 days the scar was thicker 
for the hydrogel-treated wounds (1072 µm ± 300) than that of the 
untreated controls (719 µm ± 250). The reverse pattern was seen after 
14 days (PEG-fib hydrogel: 543 µm ± 92, control: 663 µm ± 129). 
These differences between treatments at both time points were also not 
statistically significant. The calculated vertical compression of the scar 
was not significantly different between groups at either time points.
The mean horizontal contraction rate (%) in the 7-days group was 
calculated to be higher for the controls (56.61% ± 19.49) than for the 
PEG-fib hydrogel treated wounds (48.92 ± 12.23%). After 14 days this 
was reversed to a lower percentage for the controls (65.27% ± 15.14) 
than for the PEG-fib hydrogel treated ones (77.6 ± 7.72%) as shown in 
Table 3. These different values lead to a significant increase in wound 
contraction between day 7 and 14 for the PEG-fib hydrogel treated 
wounds (p=0.014, Table 3).
The calculation of newly built epithelium (NBE) showed no 
statistically significant differences comparing groups and time points 
(Table 3).
With regards to alpha-SMA expression, there were low levels 
expressed on day 7 (Figures 6a and 6b) in both groups, but no 
observable differences in the expression pattern after 14 days. There 
were no statistically significant differences in alpha-SMA expression 
levels between the treated and control groups at either time points 
(Table 2).
Discussion
Biomaterial scaffolds can provide distinct advantages in the 
treatment of difficult skin wounds; they can provide structural support 
and hydration to the wound bed, with additional versatility afforded 
through specific bioactivity at the material-cell interface [28]. 
In this preliminary study, the biocompatibility of a PEG-fib 
hydrogel applied in a skin defect in rats was evaluated, with a focus on 
the cellular reactions to the material, its resorption, and the subsequent 
formation of an epithelial layer in the topical application site. 
The hydrogel was easily applied onto the wounds. The gel precursor 
solution spread out in the wound quickly and homogenously and 
integrated in the whole wound area; an advantage that has been 
reported accordingly [33]. After 5 minutes exposure to UV light, the 
hydrogel polymerized with consistency of elastic gels as previously 
reported [21]. This is highly advantageous, because the hydrogel may 
then maintain wound hydration until it is degraded and if necessary 
could be reapplied at bandage changes. The hydration could also have 
been achieved through bio-occlusive foils, but these devices have to be 
tailored to the wound geometry, because they cause irritations when 
covering healthy skin [49]. Furthermore, they may delay wound healing 
[49], have no absorption capability and may therefore accumulate 
exudates underneath, that would increase the risk of bacterial growth 
and reduce epithelialization [9]. 
Because both the test and control treatments were performed in the 
same animal, a cross contamination could not completely be precluded, 
but different to liquid substances the applied material was solid and 
fixed in the wound by the bandage, so that a transfer from one wound 
into the other seems unlikely.
A second intention healing by contraction and epithelialization 
occurred in all animals as would be expected in a healthy rodent 
non-adherent skin model. After 7 days, all wounds showed a sound 
granulation tissue and advanced epithelialization. After 14 days, 6 out 
of 12 wounds were closed macroscopically: 5 wounds treated with the 
Table 3: Quantitative analysis of histological sections. The table summarizes the mean values (± standard deviation) for open wound at sacrifice (OW), total wound area 
(TWA), newly built epithelium (NBE), horizontal contraction rate percentage (HCR), scar thickness at edges (scar thickness E, mean of left and right edge), scar thickness 
in the center of the wound (scar thickness C), scar vertical depression (scar vert depr) percentage (difference between scar thickness at the edge of the wound and scar 
thickness in the center of the wound), *indicates a significant difference between 7 day value and 14 days value (n=12 wounds/timepoint), -: difference not significant.
Survival time - 7 days Survival time - 14 days Comparison 7 and 14 days: p-value
PEG-fib Control PEG-fib Control
OW (µm) 2074.83 ± 1358.74* 1212.67 ± 1431.17 0 ±0* 404.00 ± 989.59 0.024
TWA (µm) 4085.83 ± 979.14* 3470.67 ±1559.92 1792.00 ±618.01* 2778.17 ± 1211.43 0.014
NBE (µm) 2011.00 ± 1363.48 2258.00 ±1383.93 1792 ±618.01 2374.17 ± 1289.42 -
HCR % 48.93 ± 12.24* 56.62 ± 19.50 77.60 ± 7.73* 65.27 ± 15.14 0.014
Scar thickness E (µm) 1017.08 ± 126.23* 808.42 ± 227.16 592.33 ± 111.81* 608.08 ± 48.61 0.001
Scar thickness C (µm) 1072.5 ± 300.53* 719.33 ± 250.36 543.83 ± 92.92* 663.5 ± 129.60 0.002
Scar vert. depr % -4.25 ± 20.05 10.76 ± 22.50 7.16 ± 13.83 -9.50 ± 21.32 -
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PEG-fibrinogen hydrogel and one of the untreated wounds. This is 
probably due to the effect of the hydrogel wound coverage, preserving 
a humid milieu throughout the treatment. It is generally accepted that 
maintaining a wet wound environment accelerates epithelialization 
[8,9]. It may also be a result of an interaction between the fibrinogen 
and inflammatory cells in the wound. 
In our skin wound model the biomaterial showed good 
biocompatibility with no evidence of an unusual cellular reaction. 
This is in accordance with other in-vivo experiments where PEG-fib 
hydrogel biomaterials with progenitor cells were injected into the tibialis 
anterior muscle of mice [42]. It was shown that the PEG-fib hydrogels 
provided immediate protection from host inflammation for the implant 
progenitor cells. It also enhanced cell proliferation in acutely damaged 
and dystrophic muscles, leading to functional recovery of myofibers 
[42].
The cells detected in the histological sections of both groups at the 
two time points corresponded to the physiological cell repopulation 
in a healing skin defect. The short exposure to long-wave UV light 
radiation seems not to be cytotoxic to cells as it was already shown 
in vitro [39] and in vivo [42]. When comparing the untreated and 
hydrogel-treated wounds, there was no difference in the number of 
immune cells like FBGCs, macrophages, plasma cells and lymphocytes. 
Few of those cells, however, were seen in both groups as an indicator 
of an acute inflammatory reaction. Cell numbers in the hydrogel 
treated wounds may also be related to the higher load of material that 
requires breakdown by phagocytosis. Signs for incompatibility of the 
applied material such as high numbers of FBGCs in clusters, were not 
present. This is in accordance with findings of a study where the PEG-
fibrinogen was implanted in subcutaneous pockets [32] in rats. Based 
on the prevailing evidence from these experimental observations, it 
can be stated that PEG-fib hydrogel is biocompatible for this intended 
application because no adverse consequences of the implanted material 
are evident, most notably no fibrous capsule was formed that might lead 
to unsatisfactory healing. 
As for persistence of the PEG-fib hydrogel, remnants of the applied 
gel were found only in two of the treated wounds at the 7 days’ time 
point, and no remnants were evident at the 14 days’ time point. 
These findings are comparable to two in vivo rat studies, where PEG-
fibrinogen was implanted in a subcutaneous pocket. The surface erosion 
of the bulk implant started at day 8 [32]. The model, where the hydrogel 
was polymerized in situ, showed a complete disassembly of the PEG-
fibrinogen within 2 weeks, with an average of 90% material dissolved 
during the first week [33]. The rate of the PEG-fibrinogen degradation 
is highly dependent on the implantation site and the composition of 
the implant material. Previous studies demonstrated that the rate of 
biodegradation of the PEG-fib hydrogels could be affected both by the 
molecular weight of the grafted PEG, the molecular structure of the 
protein backbone [21] and the geometry of the implant [33]. Therefore, 
degradation kinetics can be changed in future studies using these 
material design parameters, if a longer persistence of the biomaterial in 
the wound is desired, e.g. in larger or deeper wounds. 
The evaluation of the fibroblast maturity in the histological sections 
showed a partially mature tissue after 7 days, and almost completed 
tissue maturity after 14 days for both groups. There was a tendency for 
a higher tissue maturity of the PEG-fib hydrogel treated wounds after 
14 days in the middle of the defect. This confirms previous results of 
in vitro studies with PEG-hydrogels [21,42]. Differentiation of newly 
built tissue is also supported by the fact that a basal membrane [50] 
was visible in all sections of the PEG-fib hydrogel treated and untreated 
control wounds at the 14 days’ time point.
A significant reduction of blood vessels between day 7 and 14 
was seen in the sections of both the control and the hydrogel treated 
groups. This reduction can be interpreted as a histological sign for 
uncomplicated healing, because prolonged vascularity is a sign of a 
scar that is likely to remain prominent [51]. In humans, the reduction 
of vessels does not begin until 2-3 weeks after the injury. The early 
reduction before day 14 can be most likely attributed to the rat model, 
where overall healing is faster than in most species, as shown by other 
authors [51].
After 7 days the amount of newly built tissue was greater in the 
untreated wounds, and therefore the open wound area was smaller 
for this group. However, after 14 days, all the PEG-fibrinogen-treated 
wounds were categorized as “closed” in the histological sections, while 
in the control wounds, an average open wound of 404 µm was still 
Figure 6a: Expression of alpha-SMA in granulation tissue of the healing wound 7 days 
after surgery (arrows). 
Figure 6a: Expression of alpha-SMA in granulation tissue of the healing wound 
7 days after surgery (arrows). 
Figure 6b: Expression of alpha-SMA in granulation tissue of the healing wound 7 days after surgery (black 
arrows). Note that alpha-SMA is also expressed in different proportions in arterial walls by local smooth 
muscle cells (discontinuous arrows).
Figure 6b: Expression of al ha-SMA in granulation tissue of the healing 
wound 7 days after surgery (black arrows). Note that alpha-SMA is also 
expressed in different proportions in arterial walls by local smooth muscle cells 
(discontinuous arrows).
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observed. This was contrary to the macro-evaluation in one hydrogel-
treated sample, were we saw signs for an open wound. Probably just 
a crust attached to the underlying healed epithelium lead to this 
misinterpretation [52]. When comparing the percentage of scar 
depression, it could be shown that after 7 days the treated wounds did 
not exhibit any scar depression in contrast to the untreated controls. 
After 14 days this difference was no longer evident. We speculate, 
that the positive results shown for the first week could be due to the 
structural support provided by the hydrogel, which allowed faster 
repair and subsequently faster remodeling between days 7 and 14. As a 
result, the thickness of the scar tissue was reduced.
Consequently, a wound contraction rate of 58% after 7 days and 
additionally 20% between 7 and 14 days was calculated. This rate is 
comparable to the data given in the literature where 50-90% wound 
contraction was seen in excisional wound in rats, depending on wound 
geometry, anatomical location and the presence or absence of panniculus 
carnosus [53,54]. There are models to limit wound contraction to a degree 
comparable to that of humans (25-40% [55]), including splints secured 
to the skin with adhesives [56]. However, splinting has been shown to 
alter wound healing, probably by mechanical and biochemical signaling 
in the wound, and it is not yet clear, whether the healing process induced 
by these models is actually closer to that of humans [57]. Because 
wound contraction is a direct result of myofibroblasts producing α−
smooth muscle actin (alpha-SMA) [58], it was interesting to note, that 
low amounts of alpha-SMA were evident in the sections after 7 days. 
Likewise no more alpha-SMA could be detected at day 14. Although no 
myofibroblasts were visible at 14 days’ time point, the contraction of the 
wound proceeded at the later time point, albeit to a much lesser degree. 
It is possible that histological methods were not sensitive enough, but it 
is also apparent that the myofibroblasts is not the only cell that generates 
contractile forces within wounds [58,59]. The significant drop of visible 
alpha-SMA over time is a sign for normal wound healing, where the 
myofibroblasts progressively disappear in the scar [60].
This study also has some limitations. First, the rat was chosen as 
the experimental animal model. On the one hand clinical observations 
generally indicate that wound healing follows the same basic pattern 
in most species and therefore a relatively homogenous process across 
species lines is assumed [47]. On the other hand, healing of rat wounds 
does not perfectly mimic the situation in full-thickness wounds of 
humans, because the skin morphology is somewhat different [54]. In 
addition, the wound contraction rate in rodents is higher [52] and the 
healing process is accelerated due to their faster overall metabolism 
[53]. Compared to the complexity of human chronic wounds the rodent 
model is relatively simple. However, the use of rodent models is fairly 
representative of acute wound healing in humans and accepted to test 
biocompatibility issues of novel biomaterials [61]. 
A second limitation of the study is the location of wounds. Wound 
location is highly relevant, because the wound contraction rate is 
variable in how tightly the skin is adherent to the underlying tissue [54]. 
Although location and the skin punch technique were standardized, 
the resulting size and shape varied to a certain extent. This is due to 
the remaining skin’s elastic forces [62], which may deform the circular 
defect into an ellipse. The randomization of treatments can compensate 
for this effect, while higher animal numbers would equalize the 
differences. However, this preliminary study with a relatively small 
number of animals served mainly for testing the biocompatibility of 
the PEG-fib hydrogel. A pivotal study with higher animal numbers 
and additional time points is planned to address the functionality of 
the PEG-fib hydrogel in comparison to standard controls and other 
hydrogel biomaterials. 
The 8-mm defect model represents the healing of a relatively small, 
acute and non-infected wound, which usually heals without major 
problems in human patients. The need for new ways to treat larger 
wounds and chronic/infected wounds will require a different model 
[63,64]. Furthermore, different experimental animals will be required 
(e.g. pigs [64-66]) to be closer to the clinical situation of non-healing 
wounds in humans.
In conclusion, these findings indicate that the PEG-fib hydrogel 
is fully biocompatible in skin wounds (corroboration of hypothesis 
2). The PEG-fib can be used as an in situ polymerizable biomaterial 
that gradually resorbs into the wound within a 2-week time frame. As 
a conductive biomaterial (non-functionalized), it did not accelerate 
wound healing (rejection of hypothesis 1). Future studies using the 
biocompatible PEG-fib hydrogel can be performed with prepopulated 
living skin cells (e.g. fibroblasts) and/or loaded with growth factors or 
other soluble mediators, in order to identify a repair strategy that may 
accelerate skin wound healing.
Acknowledgement
The authors acknowledge Prof. Dr. med. vet. Frederik J. van Sluijs, Dipl. ECVS, 
for his invaluable advice with the manuscript. The authors also acknowledge Ms. 
Aymone Lenisa for preparing excellent histological sections and Ms. Flora Nicholls 
for her help with anesthesia.
References
1. Powers JG, Higham C, Broussard K, Phillips TJ (2016) Wound healing and 
treating wounds: Chronic wound care and management. J Am Acad Dermatol 
74: 607-625. 
2. Eming SA, Martin P, Tomic-Canic M (2014) Wound repair and regeneration: 
Mechanisms, signaling, and translation. Sci Transl Med 6: 265sr6. 
3. Reinke JM, Sorg H (2012) Wound repair and regeneration. Eur Surg Res 49: 
35-43. 
4. Eming SA, Krieg T, Davidson JM (2007) Inflammation in wound repair: 
Molecular and cellular mechanisms. J Invest Dermatol 127: 514-525. 
5. Leung A, Crombleholme TM, Keswani SG (2012) Fetal wound healing: 
Implications for minimal scar formation. Curr Opin Pediatr 24: 371-378. 
6. Seaman S (2002) Dressing selection in chronic wound management. J Am 
Podiatr Med Assoc 92: 24-33. 
7. Wasiak J, Cleland H, Campbell F (2008) Dressings for superficial and partial 
thickness burns. Cochrane Database Syst Rev CD002106. 
8. Winter GD (1963) Effect of air exposure and occlusion on experimental human 
skin wounds. Nature 200: 378-379. 
9. Huang YC, Chu HW, Huang CC, Wu WC, Tsai JS (2015) Alkali-treated konjac 
glucomannan film as a novel wound dressing. Carbohydr Polym 117: 778-787. 
10. Lee K, Rowely J, Eislet P, Moy E, Bouhadir K, et al. (2000) Controlling 
mechanical and swelling properties of alginate hydrogels independently by 
cross-linker type and cross-linking density. Macromolecules 33: 4291-4294. 
11. Williams DF (2008) On the mechanisms of biocompatibility. Biomaterials 29: 
2941-2953. 
12. Jones JA, Dadsetan M, Collier TO, Ebert M, Stokes KS, et al. (2004) 
Macrophage behavior on surface-modified polyurethanes. J Biomater Sci 
Polym Ed 15: 567-584. 
13. McBane JE, Sharifpoor S, Cai K, Labow RS, Santerre JP (2011) Biodegradation 
and in vivo biocompatibility of a degradable, polar/hydrophobic/ionic 
polyurethane for tissue engineering applications. Biomaterials 32: 6034-6044. 
14. Hubbell JA (2003) Materials as morphogenetic guides in tissue engineering. 
Curr Opin Biotechnol 14: 551-558. 
15. Bryant S, Arthur J, Anseth K (2005) Incorporation of tissue-specific molecules 
alters chondrocyte metabolism and gene expression in photo-cross-linked 
hydrogels. Acta Biomater 1: 243-252. 
16. Appelman TP, Mizrahi J, Elisseeff JH, Seliktar D (2011) The influence of 
Citation: Venzin CM, Jacot V, Berdichevsky A, Karol AA, Seliktar D, et al. (2016) Biocompatibility of Pegylated Fibrinogen and Its Effect on Healing of 
Full-Thickness Skin Defects: A Preliminary Study in Rats. J Biotechnol Biomater 6: 233. doi:10.4172/2155-952X.1000233
Page 9 of 10
Volume 6 • Issue 2 • 1000233
J Biotechnol Biomater
ISSN: 2155-952X JBTBM, an open access journal 
biological motifs and dynamic mechanical stimulation in hydrogel scaffold 
systems on the phenotype of chondrocytes. Biomaterials 32: 1508-1516. 
17. Roberts MJ, Bentley MD, Harris JM (2002) Chemistry for peptide and protein 
PEGylation. Adv Drug Deliv Rev 54: 459-476. 
18. Leach J, Bivens K, Collins C, Schmidt C (2004) Development of 
photocrosslinkable hyaluronic acid-polyethylene glycol-peptide composite 
hydrogels for soft tissue engineering. J Biomed Mater Res A 70: 74-82. 
19. Leach J, Schmidt C (2005) Characterization of protein release from photo-
cross-linkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering 
scaffolds. Biomaterials 26: 125-135. 
20. Gonen-Wadmany M, Goldshmid R, Seliktar D (2011) Biological and mechanical 
implications of PEGylating proteins into hydrogel biomaterials. Biomaterials 32: 
6025-6033. 
21. Almany L, Seliktar D (2005) Biosynthetic hydrogel scaffolds made from 
fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 26: 2467-
2477. 
22. Dikovsky D, Bianco-Peled H, Seliktar D (2006) The effect of structural 
alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology 
and cellular migration. Biomaterials 27: 1496-1506. 
23. Gonen-Wadmany M, Oss-Ronen L, Seliktar D (2007) Protein–polymer 
conjugates for forming photopolymerizable biomimetic hydrogels for tissue 
engineering. Biomaterials 28: 3876-3886. 
24. Peled E, Boss J, Bejar J, Zinman C, Seliktar D (2007) A novel poly(ethylene 
glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model. J 
Biomed Mater Res A 80: 874-884. 
25. Schmidt O, Mizrahi J, Elisseeff J, Seliktar D (2006) Immobilized fibrinogen in 
PEG hydrogels does not improve chondrocyte-mediated matrix deposition in 
response to mechanical stimulation. Biotechnol Bioeng 95: 1061-1069. 
26. Nerem RM, Seliktar D (2001) Vascular tissue engineering. Annu Rev Biomed 
Eng 3: 225-243. 
27. Shapira-Schweitzer K, Seliktar D (2007) Matrix stiffness affects spontaneous 
contraction of cardiomyocytes cultured within a PEGylated fibrinogen 
biomaterial. Acta Biomaterialia 3: 33-41. 
28. Shachaf Y, Gonen-Wadmany M, Seliktar D (2010) The biocompatibility of 
PluronicF127 fibrinogen-based hydrogels. Biomaterials 31: 2836-2847. 
29. Seliktar D (2005) Extracellular stimulation in tissue engineering. Ann N Y Acad 
Sci 1047: 386-394. 
30. Frisman I, Seliktar D, Bianco-Peled H (2010) Nanostructuring of PEG-fibrinogen 
polymeric scaffolds. Acta Biomater 6: 2518-2524. 
31. Saadi T, Nayshool O, Carmel J, Ariche A, Bramnik Z, et al. (2014) Cellularized 
biosynthetic micro-hydrogel polymers, for intravascular liver tissue regeneration 
therapy. Tissue Eng Part A 20: 2850-2859.
32. Berdichevski A, Shachaf Y, Wechsler R, Seliktar D (2015) Protein composition 
alters in vivo resorption of PEG-based hydrogels as monitored by contrast-
enhanced MRI. Biomaterials 42: 1-10. 
33. Berdichevski A, Simaan Yameen H, Dafni H, Neeman M, Seliktar D (2015) 
Using bimodal MRI/fluorescence imaging to identify host angiogenic response 
to implants. Proc Natl Acad Sci U S A 112: 5147-5152. 
34. Elisseeff J, McIntosh W, Anseth K, Riley S, Ragan P, et al. (2000) 
Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-
interpenetrating networks. J Biomed Mater Res 51: 164-171. 
35. Nguyen KT, West JL (2002) Photopolymerizable hydrogels for tissue 
engineering applications. Biomaterials 23: 4307-4314. 
36. Shapira-Schweitzer K, Habib M, Gepstein L, Seliktar D (2009) A 
photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-
derived cardiomyocytes and rat neonatal cardiac cells. J Mol Cell Cardiol 46: 
213-224. 
37. Seliktar D, Zisch AH, Lutolf MP, Wrana JL, Hubbell JA (2004) MMP-2 sensitive, 
VEGF-bearing bioactive hydrogels for promotion of vascular healing. J Biomed 
Mater Res A 68: 704-716. 
38. Seliktar D, Nerem RM, Galis ZS (2003) Mechanical strain-stimulated remodeling 
of tissue-engineered blood vessel constructs. Tissue Eng 9: 657-666. 
39. Mironi-Harpaz I, Wang DY, Venkatraman S, Seliktar D (2012) 
Photopolymerization of cell-encapsulating hydrogels: Crosslinking efficiency 
versus cytotoxicity. Acta Biomater 8: 1838-1848. 
40. Plotkin M, Vaibavi SR, Rufaihah AJ, Nithya V, Wang J, et al. (2014) The effect 
of matrix stiffness of injectable hydrogels on the preservation of cardiac function 
after a heart attack. Biomaterials 35: 1429-1438. 
41. Rufaihah AJ, Vaibavi SR, Plotkin M, Shen J, Nithya V, et al. (2013) Enhanced 
infarct stabilization and neovascularization mediated by VEGF-loaded 
PEGylated fibrinogen hydrogel in a rodent myocardial infarction model. 
Biomaterials 34: 8195-8202. 
42. Fuoco C, Salvatori ML, Biondo A, Shapira-Schweitzer K, Santoleri S, et al. 
(2012) Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves 
survival and differentiation of transplanted mesoangioblasts in acute and 
chronic skeletal-muscle degeneration. Skelet Muscle 2: 24. 
43. Peled E, Boss J, Bejar J, Zinman C, Seliktar D (2007) A novel poly(ethylene 
glycol)-fibrinogen hydrogel for tibial segmental defect repair in a rat model. J 
Biomed Mater Res A 80: 874-884. 
44. Lee YB, Park SM, Song EJ, Park JG, Cho KO, et al. (2014) Histology of a 
novel injectable filler (polymethylmethacrylate and cross-linked dextran in 
hydroxypropyl methylcellulose) in a rat model. J Cosmet Laser Ther 16: 191-
196. 
45. Ikarashi Y, Toyoda K, Ohsawa N, Uchima T, Tsuchiya T, et al. (1992) 
Comparative studies by cell culture and in vivo implantation test on the toxicity 
of natural rubber latex materials. J Biomed Mater Res 26: 339-356. 
46. Hart J, Silcock D, Gunnigle S, Cullen B, Light ND, et al. (2002) The role of 
oxidized regenerated cellulose/collagen in wound repair: effects in vitro on 
fibroblast biology and in vivo in a model of compromised healing. Int J Biochem 
Cell Biol 34: 1557-1570. 
47. Bohling MW, Henderson RA, Swaim SF, Kincaid SA, Wright JC (2004) 
Cutaneous wound healing in the cat: A macroscopic description and comparison 
with cutaneous wound healing in the dog. Vet Surg 33: 579-587. 
48. Kim I, Mogford JE, Chao JD, Mustoe TA (2001) Wound epithelialization deficits 
in the transforming growth factor-alpha knockout mouse. Wound Repair Regen 
9: 386-390. 
49. Schunck M, Neumann C, Proksch E (2005) Artificial barrier repair in wounds by 
semi-occlusive foils reduced wound contraction and enhanced cell migration 
and re-epithelization in mouse skin. J Invest Dermatol 125: 1063-1071. 
50. Martin P (1997) Wound healing--aiming for perfect skin regeneration. Science 
276: 75-81. 
51. Lokmic Z, Darby IA, Thompson EW, Mitchell GM (2006) Time course analysis 
of hypoxia, granulation tissue and blood vessel growth, and remodeling in 
healing rat cutaneous incisional primary intention wounds. Wound Repair 
Regen 14: 277-288. 
52. Chen L, Mirza R, Kwon Y, et al. (2015) The murine excisional wound model: 
Contraction revisited. Wound Repair Regen 23: 874-877. 
53. Cross SE, Naylor IL, Coleman RA, Teo TC (1995) An experimental model to 
investigate the dynamics of wound contraction. Br J Plast Surg 48: 189-197. 
54. Dorsett-Martin WA (2004) Rat models of skin wound healing: A review. Wound 
Repair Regen 12: 591-599. 
55. Yannas IV (2008) The relation between wound contraction, scar formation and 
regeneration. Scar J 1: 1-15. 
56. Wang X, Ge J, Tredget EE, Wu Y (2013) The mouse excisional wound splinting 
model, including applications for stem cell transplantation. Nat Protoc 8: 302-
309. 
57. Davidson JM, Yu F, Opalenik SR (2013) Splinting strategies to overcome 
confounding wound contraction in experimental animal models. Adv Wound 
Care (New Rochelle) 2: 142-148. 
58. Ibrahim MM, Chen L, Bond JE, Medina MA, Ren L, et al. (2015) Myofibroblasts 
contribute to but are not necessary for wound contraction. Lab Invest 95: 1429-
1438. 
59. Nedelec B, Ghahary A, Scott PG, Tredget EE (2000) Control of wound 
contraction. Basic and clinical features. Hand Clin 16: 289-302. 
60. Desmoulière A (1995) Factors influencing myofibroblast differentiation during 
wound healing and fibrosis. Cell Biol Int 19: 471-476. 
Citation: Venzin CM, Jacot V, Berdichevsky A, Karol AA, Seliktar D, et al. (2016) Biocompatibility of Pegylated Fibrinogen and Its Effect on Healing of 
Full-Thickness Skin Defects: A Preliminary Study in Rats. J Biotechnol Biomater 6: 233. doi:10.4172/2155-952X.1000233
Page 10 of 10
Volume 6 • Issue 2 • 1000233
J Biotechnol Biomater
ISSN: 2155-952X JBTBM, an open access journal 
61. Frank S, Kämpfer H (2003) Excisional wound healing. An experimental 
approach. Methods Mol Med 78: 3-15. 
62. Montandon D, D'andiran G, Gabbiani G (1977) The mechanism of wound 
contraction and epithelialization: clinical and experimental studies. Clin Plast 
Surg 4: 325-346. 
63. Kanno E, Toriyabe S, Zhang L, Imai Y, Tachi M (2010) Biofilm formation on 
rat skin wounds by Pseudomonas aeruginosa carrying the green fluorescent 
protein gene. Exp Dermatol 19: 154-156. 
64. Roy S, Biswas S, Khanna S, Gordillo G, Bergdall V, et al. (2009) Characterization 
of a preclinical model of chronic ischemic wound. Physiol Genomics 37: 211-224. 
65. Middelkoop E, van den Bogaerdt AJ, Lamme EN, Hoekstra MJ, Brandsma K, 
et al. (2004) Porcine wound models for skin substitution and burn treatment. 
Biomaterials 25: 1559-1567. 
66. Sabino F, Hermes O, Egli FE, Kockmann T, Schlage P, et al. (2015) In vivo 
assessment of protease dynamics in cutaneous wound healing by degradomics 
analysis of porcine wound exudates. Mol Cell Proteomics 14: 354-370.















Citation: Citation: Venzin CM, Jacot V, Berdichevsky A, Karol AA, Seliktar D, 
et al. (2016) Biocompatibility of Pegylated Fibrinogen and Its Effect on Healing 
of Full-Thickness Skin Defects: A Preliminary Study in Rats. J Biotechnol 
Biomater 6: 233. doi:10.4172/2155-952X.1000233
